Phase I clinical trial of a single-dose and two weekly schedules of ICRF-159 (NSC-129943).

Autor: Creaven PJ, Cohen MH, Hansen HH, Selawry OS, Taylor SG 3rd
Jazyk: angličtina
Zdroj: Cancer chemotherapy reports [Cancer Chemother Rep] 1974 May-Jun; Vol. 58 (3), pp. 393-400.
Databáze: MEDLINE